--- title: Leidos (LDOS) — intrinsic value and fair price canonical: https://sweetvaluelab.com/stocks/ldos ticker: LDOS as_of: 2026-10-17 sector: Technology industry: Information Technology Services --- # Leidos (LDOS) Leidos (LDOS) closed at $124.85 on Oct 16, 2026, undervalued by 53% vs its model value of $265.15 (from a five-year discounted cash flow). ## Key figures | Figure | Value | | --- | ---: | | Last close | $124.85 (Oct 16, 2026) | | Model value (from a five-year discounted cash flow) | $265.15 | | Price vs model | undervalued by 53% vs model | | Range of that model | $149.36 – $696.06 | | Market value | $15.7B | | P/E (fiscal 2026) | 11.2 | | Net margin (fiscal 2026) | 8.5% | | Free cash flow (fiscal 2026) | $1.6B | | Dividend yield (trailing twelve months) | 1.38% | | Beta | 0.59 | | Cost of capital (WACC) | 7.13% | | Business classification | Mature & Stable (Low/slowing growth (~6% recent), Moderate margins (8% net margin), Highly cyclical earnings, Strong FCF yield (10.4%)) | ## On the stock lists | List | Place | Figure | Page | | --- | ---: | ---: | --- | | Highest free cash flow yield | #31 | 10.4% | https://sweetvaluelab.com/lists/highest-free-cash-flow-yield | | Lowest P/E | #26 | 11.2× | https://sweetvaluelab.com/lists/lowest-pe | | Worst performing this year | #35 | −30.8% | https://sweetvaluelab.com/lists/worst-performing-this-year | ## Dividends | Figure | Value | | --- | ---: | | Trailing dividend yield | 1.38% | | Dividends per share, last 12 months | $1.72 | | Coverage | — | | Raised | 7 years in a row | | Growth over 5 years | 4.5% a year | | Latest payment | $0.43, ex-date Sep 15, 2026, paid Sep 30, 2026 | | Year of payments | Dividends per share | | --- | ---: | | To Sep 14, 2021 | $1.38 | | To Sep 14, 2022 | $1.44 | | To Sep 14, 2023 | $1.44 | | To Sep 13, 2024 | $1.52 | | To Sep 15, 2025 | $1.60 | | Trailing twelve months (to Sep 15, 2026) | $1.72 | ## Valuation models Each model's value per share and the role the engine gave it for this business. The headline above is one model's value; every other model is listed with its own, and each has a page of its own under the valuation. Computed Oct 17, 2026. | Model | Role | Value per share | Low | High | | --- | --- | ---: | ---: | ---: | | DCF · Perpetuity growth · 5y | primary | $265.15 | $149.36 | $696.06 | | DCF · Perpetuity growth · 10y | cross check | $276.03 | $161.23 | $708.26 | | DCF · EBITDA exit · 5y | cross check | $201.87 | $129.68 | $287.25 | | DCF · EBITDA exit · 10y | cross check | $221.50 | $145.65 | $323.48 | | P/E · peers | cross check | $212.52 | $190.79 | $361.63 | | P/E · own history | cross check | $227.15 | $197.42 | $251.09 | | PEG | sanity check | $99.08 | $99.08 | $99.08 | | EV/EBITDA · peers | cross check | $192.75 | $166.70 | $216.79 | | EV/Revenue · peers | cross check | $99.47 | $82.56 | $299.01 | | Earnings power value | cross check | $55.72 | $41.31 | $77.81 | | Dividend discount | cross check | $32.69 | $21.55 | $58.94 | ## Insider activity (SEC Form 4) Past 90 days: 0 open-market buys ($0) and 3 open-market sales ($1.5M); 10b5-1 plan sales included. | Date | Insider | Relationship | Transaction | Shares | Value | | --- | --- | --- | --- | ---: | ---: | | Oct 7, 2026 | KRAEMER HARRY M JANSEN JR | Director | Grant / award | 297.226 | $0 | | Sep 30, 2026 | Antal Daniel J. | EVP, General Counsel | Grant / award | 4.711 | $0 | | Sep 30, 2026 | Cage Christopher R | Chief Financial Officer | Grant / award | 92.778 | $0 | | Sep 30, 2026 | Stevens Roy E | Sector President | Grant / award | 6.394 | $0 | | Sep 30, 2026 | KRAEMER HARRY M JANSEN JR | Director | Grant / award | 463.07 | $0 | ## Recent SEC filings | Filed | Form | What | Filing | | --- | --- | --- | --- | | Oct 5, 2026 | 8-K | 1.01 Entry into a Material Agreement; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1336920/000119312526413208/d157380d8k.htm | | Oct 1, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1336920/000133692026000265/ldos-20261001.htm | | Aug 4, 2026 | 10-Q | Quarterly report | https://www.sec.gov/Archives/edgar/data/1336920/000133692026000246/ldos-20260703.htm | | Aug 4, 2026 | 8-K | 2.02 Results of Operations (Earnings); 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1336920/000133692026000243/ldos-20260804.htm | | May 6, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers; 5.07 Submission of Matters to a Shareholder Vote; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1336920/000133692026000177/ldos-20260501.htm | ## Superinvestors holding it (latest 13F) | Manager | Quarter | Shares | Value | | --- | --- | ---: | ---: | | Richard Pzena | 2026-06-30 | 247,849 | $25.5M | | Bridgewater | 2026-06-30 | 158,669 | $16.3M | 2 tracked managers in all. ## About Leidos Holdings, Inc., along with its various subsidiaries, delivers a broad spectrum of services and innovative solutions across key markets: defense, intelligence, civil government, and health. The company operates both domestically within the United States and on an international scale. Its operations are organized into three principal divisions: Defense Solutions, Civil, and Health. The Defense Solutions segment is dedicated to providing national security systems and specialized support spanning air, land, sea, space, and cyberspace domains. Its extensive client base includes the U.S. Intelligence Community, the Department of Defense, NASA, various military branches, allied foreign governments, and other federal and commercial entities within the national security sector. This division's offerings encompass advanced technology, large-scale systems integration, command and control pla… --- Source: https://sweetvaluelab.com/stocks/ldos (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.